Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

ACHC vs UNH vs CVS vs UHS vs OSCR

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ACHC
Acadia Healthcare Company, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$2.25B
5Y Perf.-57.2%
UNH
UnitedHealth Group Incorporated

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$335.60B
5Y Perf.-0.6%
CVS
CVS Health Corporation

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$111.40B
5Y Perf.+16.1%
UHS
Universal Health Services, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$10.68B
5Y Perf.+27.9%
OSCR
Oscar Health, Inc.

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$5.41B
5Y Perf.-22.4%

ACHC vs UNH vs CVS vs UHS vs OSCR — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ACHC logoACHC
UNH logoUNH
CVS logoCVS
UHS logoUHS
OSCR logoOSCR
IndustryMedical - Care FacilitiesMedical - Healthcare PlansMedical - Healthcare PlansMedical - Care FacilitiesMedical - Healthcare Plans
Market Cap$2.25B$335.60B$111.40B$10.68B$5.41B
Revenue (TTM)$3.37B$449.71B$407.90B$17.76B$13.30B
Net Income (TTM)$-1.11B$12.04B$2.93B$1.52B$-39M
Gross Margin56.2%18.8%13.9%67.6%17.4%
Operating Margin11.7%4.2%1.5%11.5%0.1%
Forward P/E16.4x20.2x12.2x7.3x34.7x
Total Debt$2.65B$78.39B$93.59B$5.51B$430M
Cash & Equiv.$133M$24.36B$8.51B$138M$2.77B

ACHC vs UNH vs CVS vs UHS vs OSCRLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ACHC
UNH
CVS
UHS
OSCR
StockMar 21May 26Return
Acadia Healthcare C… (ACHC)10042.8-57.2%
UnitedHealth Group … (UNH)10099.4-0.6%
CVS Health Corporat… (CVS)100116.1+16.1%
Universal Health Se… (UHS)100127.9+27.9%
Oscar Health, Inc. (OSCR)10077.6-22.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: ACHC vs UNH vs CVS vs UHS vs OSCR

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CVS and UHS are tied at the top with 3 categories each (5-stock set) — the right choice depends on your priorities. Universal Health Services, Inc. is the stronger pick specifically for valuation and capital efficiency and profitability and margin quality. OSCR also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
ACHC
Acadia Healthcare Company, Inc.
The Healthcare Pick

ACHC lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
UNH
UnitedHealth Group Incorporated
The Insurance Pick

UNH is the clearest fit if your priority is income & stability and growth exposure.

  • Dividend streak 25 yrs, beta 0.59, yield 2.4%
  • Rev growth 11.8%, EPS growth -14.7%, 3Y rev CAGR 11.4%
  • 220.6% 10Y total return vs UHS's 30.8%
Best for: income & stability and growth exposure
CVS
CVS Health Corporation
The Insurance Pick

CVS carries the broadest edge in this set and is the clearest fit for defensive.

  • Beta 0.05, yield 3.1%, current ratio 0.84x
  • Beta 0.05 vs OSCR's 1.84
  • 3.1% yield, vs UNH's 2.4%, (2 stocks pay no dividend)
  • +34.7% vs UHS's -8.2%
Best for: defensive
UHS
Universal Health Services, Inc.
The Defensive Pick

UHS is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.

  • Lower volatility, beta 0.60, Low D/E 74.3%, current ratio 1.05x
  • Lower P/E (7.3x vs 20.2x)
  • 8.6% margin vs ACHC's -32.8%
  • 9.8% ROA vs ACHC's -18.6%, ROIC 12.3% vs 5.9%
Best for: sleep-well-at-night
OSCR
Oscar Health, Inc.
The Insurance Pick

OSCR ranks third and is worth considering specifically for growth.

  • 27.5% revenue growth vs ACHC's 5.0%
Best for: growth
See the full category breakdown
CategoryWinnerWhy
GrowthOSCR logoOSCR27.5% revenue growth vs ACHC's 5.0%
ValueUHS logoUHSLower P/E (7.3x vs 20.2x)
Quality / MarginsUHS logoUHS8.6% margin vs ACHC's -32.8%
Stability / SafetyCVS logoCVSBeta 0.05 vs OSCR's 1.84
DividendsCVS logoCVS3.1% yield, vs UNH's 2.4%, (2 stocks pay no dividend)
Momentum (1Y)CVS logoCVS+34.7% vs UHS's -8.2%
Efficiency (ROA)UHS logoUHS9.8% ROA vs ACHC's -18.6%, ROIC 12.3% vs 5.9%

ACHC vs UNH vs CVS vs UHS vs OSCR — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ACHCAcadia Healthcare Company, Inc.
FY 2025
United States Facilities
100.0%$3.3B
UNHUnitedHealth Group Incorporated
FY 2025
Unitedhealthcare
94.4%$332.4B
Optumhealth
5.6%$19.8B
CVSCVS Health Corporation
FY 2025
Pharmacy Revenue
58.9%$229.0B
Premiums
34.6%$134.8B
Front Store Revenue
5.5%$21.5B
Product and Service, Other
1.0%$3.9B
UHSUniversal Health Services, Inc.
FY 2025
Acute Care Hospital Services
57.2%$9.9B
Behavioral Health Services
42.8%$7.4B
OSCROscar Health, Inc.

Segment breakdown not available.

ACHC vs UNH vs CVS vs UHS vs OSCR — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCVSLAGGINGUNH

Income & Cash Flow (Last 12 Months)

OSCR leads this category, winning 3 of 6 comparable metrics.

UNH is the larger business by revenue, generating $449.7B annually — 133.4x ACHC's $3.4B. UHS is the more profitable business, keeping 8.6% of every revenue dollar as net income compared to ACHC's -32.8%. On growth, OSCR holds the edge at +52.6% YoY revenue growth, suggesting stronger near-term business momentum.

MetricACHC logoACHCAcadia Healthcare…UNH logoUNHUnitedHealth Grou…CVS logoCVSCVS Health Corpor…UHS logoUHSUniversal Health …OSCR logoOSCROscar Health, Inc.
RevenueTrailing 12 months$3.4B$449.7B$407.9B$17.8B$13.3B
EBITDAEarnings before interest/tax$588M$23.2B$10.5B$2.7B$40M
Net IncomeAfter-tax profit-$1.1B$12.0B$2.9B$1.5B-$39M
Free Cash FlowCash after capex-$215M$19.7B$7.4B$894M$2.8B
Gross MarginGross profit ÷ Revenue+56.2%+18.8%+13.9%+67.6%+17.4%
Operating MarginEBIT ÷ Revenue+11.7%+4.2%+1.5%+11.5%+0.1%
Net MarginNet income ÷ Revenue-32.8%+2.7%+0.7%+8.6%-0.3%
FCF MarginFCF ÷ Revenue-6.4%+4.4%+1.8%+5.0%+21.0%
Rev. Growth (YoY)Latest quarter vs prior year+7.6%+2.0%+6.2%+9.6%+52.6%
EPS Growth (YoY)Latest quarter vs prior year-49.8%+0.7%+63.1%+17.7%+125.0%
OSCR leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

Evenly matched — UHS and OSCR each lead in 2 of 6 comparable metrics.

At 7.4x trailing earnings, UHS trades at a 88% valuation discount to CVS's 62.8x P/E. On an enterprise value basis, UHS's 6.1x EV/EBITDA is more attractive than UNH's 16.7x.

MetricACHC logoACHCAcadia Healthcare…UNH logoUNHUnitedHealth Grou…CVS logoCVSCVS Health Corpor…UHS logoUHSUniversal Health …OSCR logoOSCROscar Health, Inc.
Market CapShares × price$2.3B$335.6B$111.4B$10.7B$5.4B
Enterprise ValueMkt cap + debt − cash$4.8B$389.6B$196.5B$16.0B$3.1B
Trailing P/EPrice ÷ TTM EPS-2.01x27.95x62.81x7.38x-12.35x
Forward P/EPrice ÷ next-FY EPS est.16.42x20.19x12.19x7.30x34.65x
PEG RatioP/E ÷ EPS growth rate0.46x
EV / EBITDAEnterprise value multiple8.27x16.70x13.11x6.14x
Price / SalesMarket cap ÷ Revenue0.68x0.75x0.28x0.61x0.46x
Price / BookPrice ÷ Book value/share1.04x3.31x1.47x1.48x5.58x
Price / FCFMarket cap ÷ FCF20.88x14.27x12.57x5.11x
Evenly matched — UHS and OSCR each lead in 2 of 6 comparable metrics.

Profitability & Efficiency

UHS leads this category, winning 6 of 9 comparable metrics.

UHS delivers a 20.7% return on equity — every $100 of shareholder capital generates $21 in annual profit, vs $-41 for ACHC. OSCR carries lower financial leverage with a 0.44x debt-to-equity ratio, signaling a more conservative balance sheet compared to CVS's 1.24x. On the Piotroski fundamental quality scale (0–9), UNH scores 6/9 vs OSCR's 4/9, reflecting solid financial health.

MetricACHC logoACHCAcadia Healthcare…UNH logoUNHUnitedHealth Grou…CVS logoCVSCVS Health Corpor…UHS logoUHSUniversal Health …OSCR logoOSCROscar Health, Inc.
ROE (TTM)Return on equity-40.9%+11.5%+3.9%+20.7%-3.3%
ROA (TTM)Return on assets-18.6%+3.9%+1.1%+9.8%-0.6%
ROICReturn on invested capital+5.9%+9.2%+5.0%+12.3%
ROCEReturn on capital employed+7.5%+9.7%+6.1%+16.0%-25.3%
Piotroski ScoreFundamental quality 0–956564
Debt / EquityFinancial leverage1.24x0.77x1.24x0.74x0.44x
Net DebtTotal debt minus cash$2.5B$54.0B$85.1B$5.4B-$2.3B
Cash & Equiv.Liquid assets$133M$24.4B$8.5B$138M$2.8B
Total DebtShort + long-term debt$2.7B$78.4B$93.6B$5.5B$430M
Interest CoverageEBIT ÷ Interest expense-5.99x4.71x2.11x10.92x-0.57x
UHS leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — CVS and OSCR each lead in 2 of 6 comparable metrics.

A $10,000 investment in CVS five years ago would be worth $11,700 today (with dividends reinvested), compared to $3,823 for ACHC. Over the past 12 months, CVS leads with a +34.7% total return vs UHS's -8.2%. The 3-year compound annual growth rate (CAGR) favors OSCR at 40.5% vs ACHC's -29.2% — a key indicator of consistent wealth creation.

MetricACHC logoACHCAcadia Healthcare…UNH logoUNHUnitedHealth Grou…CVS logoCVSCVS Health Corpor…UHS logoUHSUniversal Health …OSCR logoOSCROscar Health, Inc.
YTD ReturnYear-to-date+71.2%+10.6%+10.6%-22.3%+39.4%
1-Year ReturnPast 12 months+1.2%-3.2%+34.7%-8.2%+22.6%
3-Year ReturnCumulative with dividends-64.5%-19.9%+36.6%+20.8%+177.5%
5-Year ReturnCumulative with dividends-61.8%-2.6%+17.0%+12.5%-7.3%
10-Year ReturnCumulative with dividends-58.5%+220.6%+3.5%+30.8%-40.0%
CAGR (3Y)Annualised 3-year return-29.2%-7.1%+11.0%+6.5%+40.5%
Evenly matched — CVS and OSCR each lead in 2 of 6 comparable metrics.

Risk & Volatility

CVS leads this category, winning 2 of 2 comparable metrics.

CVS is the less volatile stock with a 0.05 beta — it tends to amplify market swings less than OSCR's 1.84 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CVS currently trades 98.5% from its 52-week high vs UHS's 69.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricACHC logoACHCAcadia Healthcare…UNH logoUNHUnitedHealth Grou…CVS logoCVSCVS Health Corpor…UHS logoUHSUniversal Health …OSCR logoOSCROscar Health, Inc.
Beta (5Y)Sensitivity to S&P 5000.84x0.59x0.05x0.60x1.84x
52-Week HighHighest price in past year$30.20$395.52$88.63$246.33$23.80
52-Week LowLowest price in past year$11.43$234.60$58.35$152.33$10.69
% of 52W HighCurrent price vs 52-week peak+81.0%+93.5%+98.5%+69.2%+87.7%
RSI (14)Momentum oscillator 0–10046.275.969.339.778.5
Avg Volume (50D)Average daily shares traded3.1M7.9M7.4M793K6.5M
CVS leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — UNH and CVS each lead in 1 of 2 comparable metrics.

Analyst consensus: ACHC as "Buy", UNH as "Buy", CVS as "Buy", UHS as "Hold", OSCR as "Hold". Consensus price targets imply 35.7% upside for UHS (target: $232) vs -19.7% for OSCR (target: $17). For income investors, CVS offers the higher dividend yield at 3.06% vs UHS's 0.47%.

MetricACHC logoACHCAcadia Healthcare…UNH logoUNHUnitedHealth Grou…CVS logoCVSCVS Health Corpor…UHS logoUHSUniversal Health …OSCR logoOSCROscar Health, Inc.
Analyst RatingConsensus buy/hold/sellBuyBuyBuyHoldHold
Price TargetConsensus 12-month target$23.50$385.43$95.20$231.50$16.75
# AnalystsCovering analysts2552414311
Dividend YieldAnnual dividend ÷ price+2.4%+3.1%+0.5%
Dividend StreakConsecutive years of raises12501
Dividend / ShareAnnual DPS$8.70$2.67$0.80
Buyback YieldShare repurchases ÷ mkt cap+2.2%+1.7%0.0%+9.1%0.0%
Evenly matched — UNH and CVS each lead in 1 of 2 comparable metrics.
Key Takeaway

OSCR leads in 1 of 6 categories (Income & Cash Flow). UHS leads in 1 (Profitability & Efficiency). 3 tied.

Best OverallCVS Health Corporation (CVS)Leads 1 of 6 categories
Loading custom metrics...

ACHC vs UNH vs CVS vs UHS vs OSCR: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is ACHC or UNH or CVS or UHS or OSCR a better buy right now?

For growth investors, Oscar Health, Inc.

(OSCR) is the stronger pick with 27. 5% revenue growth year-over-year, versus 5. 0% for Acadia Healthcare Company, Inc. (ACHC). Universal Health Services, Inc. (UHS) offers the better valuation at 7. 4x trailing P/E (7. 3x forward), making it the more compelling value choice. Analysts rate Acadia Healthcare Company, Inc. (ACHC) a "Buy" — based on 25 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — ACHC or UNH or CVS or UHS or OSCR?

On trailing P/E, Universal Health Services, Inc.

(UHS) is the cheapest at 7. 4x versus CVS Health Corporation at 62. 8x. On forward P/E, Universal Health Services, Inc. is actually cheaper at 7. 3x.

03

Which is the better long-term investment — ACHC or UNH or CVS or UHS or OSCR?

Over the past 5 years, CVS Health Corporation (CVS) delivered a total return of +17.

0%, compared to -61. 8% for Acadia Healthcare Company, Inc. (ACHC). Over 10 years, the gap is even starker: UNH returned +220. 6% versus ACHC's -58. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — ACHC or UNH or CVS or UHS or OSCR?

By beta (market sensitivity over 5 years), CVS Health Corporation (CVS) is the lower-risk stock at 0.

05β versus Oscar Health, Inc. 's 1. 84β — meaning OSCR is approximately 3531% more volatile than CVS relative to the S&P 500. On balance sheet safety, Oscar Health, Inc. (OSCR) carries a lower debt/equity ratio of 44% versus 124% for CVS Health Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — ACHC or UNH or CVS or UHS or OSCR?

By revenue growth (latest reported year), Oscar Health, Inc.

(OSCR) is pulling ahead at 27. 5% versus 5. 0% for Acadia Healthcare Company, Inc. (ACHC). On earnings-per-share growth, the picture is similar: Universal Health Services, Inc. grew EPS 37. 3% year-over-year, compared to -1865. 9% for Oscar Health, Inc.. Over a 3-year CAGR, OSCR leads at 41. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — ACHC or UNH or CVS or UHS or OSCR?

Universal Health Services, Inc.

(UHS) is the more profitable company, earning 8. 6% net margin versus -33. 3% for Acadia Healthcare Company, Inc. — meaning it keeps 8. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ACHC leads at 11. 7% versus -3. 4% for OSCR. At the gross margin level — before operating expenses — UHS leads at 90. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is ACHC or UNH or CVS or UHS or OSCR more undervalued right now?

On forward earnings alone, Universal Health Services, Inc.

(UHS) trades at 7. 3x forward P/E versus 34. 7x for Oscar Health, Inc. — 27. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for UHS: 35. 7% to $231. 50.

08

Which pays a better dividend — ACHC or UNH or CVS or UHS or OSCR?

In this comparison, CVS (3.

1% yield), UNH (2. 4% yield), UHS (0. 5% yield) pay a dividend. ACHC, OSCR do not pay a meaningful dividend and should not be held primarily for income.

09

Is ACHC or UNH or CVS or UHS or OSCR better for a retirement portfolio?

For long-horizon retirement investors, CVS Health Corporation (CVS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

05), 3. 1% yield). Oscar Health, Inc. (OSCR) carries a higher beta of 1. 84 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CVS: +3. 5%, OSCR: -40. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between ACHC and UNH and CVS and UHS and OSCR?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: ACHC is a small-cap quality compounder stock; UNH is a large-cap quality compounder stock; CVS is a mid-cap income-oriented stock; UHS is a mid-cap deep-value stock; OSCR is a small-cap high-growth stock. UNH, CVS pay a dividend while ACHC, UHS, OSCR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

ACHC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 33%
Run This Screen
Stocks Like

UNH

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Dividend Yield > 0.9%
Run This Screen
Stocks Like

CVS

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Dividend Yield > 1.2%
Run This Screen
Stocks Like

UHS

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

OSCR

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 26%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform ACHC and UNH and CVS and UHS and OSCR on the metrics below

Revenue Growth>
%
(ACHC: 7.6% · UNH: 2.0%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.